Chemoinformaics analysis of 2-(4-Methoxyphenyl)-3-methyloxirane
Molecular Weight | 164.204 | nRot | 2 |
Heavy Atom Molecular Weight | 152.108 | nRig | 9 |
Exact Molecular Weight | 164.084 | nRing | 2 |
Solubility: LogS | -2.982 | nHRing | 1 |
Solubility: LogP | 2.339 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 26.3055 |
nHD | 0 | BPOL | 15.5105 |
QED | 0.625 |
Synth | 2.499 |
Natural Product Likeliness | 0.766 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.464 |
MDCK | 0.0000217 |
BBB | 0.79 |
PPB | 0.712742 |
VDSS | 1.309 |
FU | 0.187204 |
CYP1A2-inh | 0.431 |
CYP1A2-sub | 0.935 |
CYP2c19-inh | 0.66 |
CYP2c19-sub | 0.859 |
CYP2c9-inh | 0.182 |
CYP2c9-sub | 0.822 |
CYP2d6-inh | 0.112 |
CYP2d6-sub | 0.902 |
CYP3a4-inh | 0.113 |
CYP3a4-sub | 0.446 |
CL | 10.066 |
T12 | 0.2 |
hERG | 0.024 |
Ames | 0.735 |
ROA | 0.1 |
SkinSen | 0.197 |
Carcinogencity | 0.732 |
EI | 0.901 |
Respiratory | 0.343 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.892178 |